M&R Capital Management’s PAVmed Inc. Series Z Warrant PAVMZ Stock Holding History

M&R Capital Management’s Portfolio PAVMZ Stock Details PAVMZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-83,335	Closed	-$32K	–	504
2019 Q4	$32K	Hold	83,335	–	–	0.01%	299
2019 Q3	$26K	Hold	83,335	–	–	0.01%	335
2019 Q2	$35K	Hold	83,335	–	–	0.01%	312
2019 Q1	$36K	Hold	83,335	–	–	0.01%	313
2018 Q4	$26K	Hold	83,335	–	–	0.01%	328
2018 Q3	$39K	Buy	+83,335	New	+$41.4K	0.01%	313

Other funds holding PAVMZ

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

M&R Capital Management's PAVMZ Position: Q1 2020 in Review

M&R Capital Management sold out of PAVmed Inc. Series Z Warrant (PAVMZ) in Q1 2020, closing a stake of 83,335 shares — an estimated $32K sold.

M&R Capital Management first reported a position in PAVMZ in Q3 2018 and held it in 6 quarters. The position peaked at $39K in Q3 2018. 7 funds tracked by Wall St. Rank hold PAVMZ as of Q1 2020.

M&R Capital Management reported no remaining PAVmed Inc. Series Z Warrant position as of Q1 2020 after selling out during the quarter.
M&R Capital Management sold 83,335 PAVmed Inc. Series Z Warrant shares in Q1 2020, an estimated $32K.
M&R Capital Management first reported a position in PAVmed Inc. Series Z Warrant in Q3 2018 and held it in 6 quarters.
M&R Capital Management's PAVmed Inc. Series Z Warrant position peaked at $39K in Q3 2018.
7 funds tracked by Wall St. Rank held PAVmed Inc. Series Z Warrant as of Q1 2020.

Based on M&R Capital Management's 13F filing for Q1 2020, filed 2 Apr 2020.